STYRENIX — Styrenix Performance Materials Balance Sheet
0.000.00%
- IN₹39.11bn
- IN₹42.91bn
- IN₹34.38bn
Annual balance sheet for Styrenix Performance Materials, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,780 | 1,031 | 1,108 | 1,084 | 1,678 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,340 | 3,262 | 3,062 | 4,725 | 4,290 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,602 | 9,221 | 6,946 | 13,607 | 13,277 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,501 | 3,213 | 3,234 | 8,823 | 10,553 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 12,319 | 12,628 | 10,379 | 22,913 | 24,826 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,909 | 4,802 | 2,565 | 6,606 | 5,808 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,755 | 5,480 | 3,151 | 11,238 | 11,163 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 8,564 | 7,147 | 7,227 | 11,676 | 13,663 |
| Total Liabilities & Shareholders' Equity | 12,319 | 12,628 | 10,379 | 22,913 | 24,826 |
| Total Common Shares Outstanding |